Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-30 | 2024-03 | 2.53 | N/A | N/A | N/A |
2024-02-06 | 2023-12 | 2.47 | 2.49 | 0.02 | 0.81% |
2023-11-02 | 2023-09 | -0.08 | 0.1 | 0.18 | 225.00% |
2023-08-08 | 2023-06 | 1.98 | 2.11 | 0.13 | 6.57% |
2023-04-27 | 2023-03 | 1.73 | 1.62 | -0.11 | -6.36% |
2023-02-02 | 2022-12 | 1.83 | 2.09 | 0.26 | 14.21% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-10-08 | Wells Fargo | Upgrade | Overweight | Overweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-01 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-04-14 | ALVAREZ RALPH | Director | 54.03K | Stock Award(Grant) |
2024-02-11 | HAKIM ANAT | General Counsel | 30.48K | Stock Award(Grant) |
2024-04-14 | HEDLEY MARY LYNNE | Director | 1.58K | Stock Award(Grant) |
2024-04-14 | JOHNSON KIMBERLY H | Director | 2.63K | Stock Award(Grant) |
2024-02-15 | LILLY ENDOWMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 98.90M | Sale |
2024-04-14 | LUCIANO JUAN R | Director | 15.68K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Lilly Endowment, Inc | 99.98M | 53.70B | 10.53% |
2023-06-29 | Vanguard Group Inc | 69.92M | 32.79B | 7.37% |
2023-06-29 | Blackrock Inc. | 64.45M | 30.23B | 6.79% |
2023-06-29 | PNC Financial Services Group, Inc. | 51.87M | 24.33B | 5.46% |
2023-06-29 | State Street Corporation | 33.88M | 15.89B | 3.57% |
2023-06-29 | FMR, LLC | 32.80M | 15.38B | 3.46% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 26.65M | 12.50B | 2.81% |
2023-06-29 | Vanguard 500 Index Fund | 18.76M | 8.80B | 1.98% |
2023-06-29 | Vanguard/Primecap Fund | 13.35M | 6.26B | 1.41% |
2023-05-30 | Fidelity 500 Index Fund | 8.83M | 3.79B | 0.93% |
2023-08-30 | SPDR S&P 500 ETF Trust | 8.68M | 4.81B | 0.91% |
2023-08-30 | iShares Core S&P 500 ETF | 7.37M | 4.08B | 0.78% |
Dividend | Date |
---|---|
1.3 | 2024-02-15 |
1.3 | 2024-02-14 |
1.13 | 2023-11-14 |
1.13 | 2023-09-08 |
1.13 | 2023-08-14 |
1.13 | 2023-05-12 |
Split | Date |
---|---|
2 : 1 | 1997-10-16 |
2 : 1 | 1995-12-21 |
2 : 1 | 1989-05-01 |
2 : 1 | 1986-01-30 |
-
“makes no sense”
youre right, it doesnt
-
JPMorgan reiterates Eli Lilly as overweight
JPMorgan said it’s bullish heading into earnings on April 30.
“More broadly on the story, LLY remains one of our favorite names in the group as we see further upside to Street estimates as Mounjaro continues to ramp and Zepbound fully launches as well as a number of additional incretin datapoints
-
Opportunity knocking
-
$LLY My Nephew works here and I ask all the time for details and he only says “buy all you can uncle
-
$LLY My Nephew works here and I ask all the time for details and he only says “buy all you can uncle
-
$LLY My Nephew works here and I ask all the time for details and he only says “buy all you can uncle”
-
$LLY Best of Breed Bitches. Viking is phase 2 years away. We are King in 5 categories. Going much higher soon.
-
$LLY Numerous Approvals Any Day Now
-
$LLY Best of Breed in Numerous Groundbreaking Areas! Alzheimers, Weight Loss, Diabetes, Liver Disease, Heart. Best!
-
$LLY Best Of Breed in 5 Major Categories
-
$LLY You have to be an Idiot to short he with Numerous Pending FDA Approvals in Life Changing Drugs. Weight Loss, Diabetes, Fatty Liver, Alzheimer’s and more. $1,700 in a year….
-
Looks like someone just bought 100K of $LLY 🤩
Nancy is that you?! -
$LLY Oversold here. Buying with both hands!
-
$LLY Only a Fool would be selling here. This stock will be $1,500+ in a year….
-
-
$LLY Shorts will be destroyed when numerous drug approvals come through soon….
-
$LLY Novo in stage 1. Years off. Lilly Best of Breed
-
$LLY , NVO Is in stage 1. Years away. Oversold
-
What You Need To Know Ahead of Eli Lilly's Earnings Report Tuesday
investopedia.com • -
LLY June 7th Options Begin Trading
news.google.com • -
MSN
news.google.com • -
Analysts Set Eli Lilly and Company (NYSE:LLY) Target Price at $728.05
news.google.com • -
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.3%
news.google.com • -
Eli Lilly & Co. stock outperforms competitors despite losses on the day
news.google.com • -
LLY (Eli Lilly and Co) Book Value per Share
news.google.com • -
Is Eli Lilly Stock A Buy After Weight-Loss Win In Sleep Apnea?
news.google.com • -
Don't Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List
investorplace.com • -
Eli Lilly & Company (LLY) Should Continue Bullish Rally
news.google.com • -
LLY vs. JNJ: Which Big Pharma Stock Is Better?- TipRanks
news.google.com • -
Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses
investorplace.com • -
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
news.google.com • -
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
news.google.com • -
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
news.google.com • -
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
news.google.com • -
Eli Lilly and Company (LLY) to Release Quarterly Earnings on Tuesday
news.google.com • -
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
news.google.com • -
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans- TipRanks
news.google.com • -
7 High-Flying Stocks That Are Majorly Overdue for a Pullback
investorplace.com • -
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S
news.google.com • -
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
marketbeat.com • -
11 Hot Growth Stocks To Buy Right Now
news.google.com • -
Bearish on SMCI & Bullish on LLY, NFLX
youtube.com • -
Strong Buy Alert: 7 No-Brainer Stocks to Scoop Up Now
investorplace.com • -
Big pharma: cautious optimism ahead of earnings season - analysts
proactiveinvestors.com • -
Eli Lilly's Chart Gets Another Boost from Obesity Drug
youtube.com • -
Eli Lilly's Weight-Loss Treatment Found To Help Those With Sleep Apnea
investopedia.com • -
Eli Lilly's weight-loss drug Zepbound might help cure your sleep apnea
fastcompany.com • -
Eli Lilly Stock Pops on Drug Efficacy for Sleep Apnea
schaeffersresearch.com • -
Eli Lilly's weightloss drug helps reduce sleep apnoea
proactiveinvestors.com • -
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
investorplace.com • -
3 Growth Stocks with Even Greater Potential Than the Magnificent 7
investorplace.com • -
Why Eli Lilly Stock Topped the Market Today
fool.com • -
The 3 Best Healthcare Stocks to Buy in April 2024
investorplace.com • -
Biotech's Next Gold Rush: Weight-Loss Drugs
youtube.com • -
5 Healthcare Stocks to Buy for 2024
investorplace.com •